CONCERT PHARMACEUTICALS, INC. 4
4 · CONCERT PHARMACEUTICALS, INC. · Filed Jul 10, 2017
Insider Transaction Report
Form 4
HERSCHA LYNETTE
General Counsel
Transactions
- Award
Common Stock
2017-07-06+50,000→ 50,000 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of the Issuer.
- [F2]50% of the RSUs granted to Ms. Herscha are eligible to vest on March 31, 2018, subject to the achievement certain performance criteria prior to March 31, 2018, including the closing of the Asset Purchase Agreement with Vertex Pharmaceuticals, Inc. and the institution by the Patent Trial and Appeal Board of a Post Grant Review petition filed by the Issuer against Incyte Corporation, and the remaining 50% of the RSUs are time-based awards and will vest on March 31, 2019. The number above represents the maximum number of shares that may be delivered pursuant to the award.
- [F3]Not applicable.